280 related articles for article (PubMed ID: 32779001)
1. The effects of β
Kunz HE; Agha NH; Hussain M; LaVoy EC; Smith KA; Mylabathula P; Diak D; Baker FL; O'Connor DP; Bond RA; Katsanis E; Bollard CM; Simpson RJ
Cell Stress Chaperones; 2020 Nov; 25(6):993-1012. PubMed ID: 32779001
[TBL] [Abstract][Full Text] [Related]
2. Systemic β-Adrenergic Receptor Activation Augments the
Baker FL; Bigley AB; Agha NH; Pedlar CR; O'Connor DP; Bond RA; Bollard CM; Katsanis E; Simpson RJ
Front Immunol; 2019; 10():3082. PubMed ID: 32038628
[TBL] [Abstract][Full Text] [Related]
3. Vigorous exercise mobilizes CD34+ hematopoietic stem cells to peripheral blood via the β
Agha NH; Baker FL; Kunz HE; Graff R; Azadan R; Dolan C; Laughlin MS; Hosing C; Markofski MM; Bond RA; Bollard CM; Simpson RJ
Brain Behav Immun; 2018 Feb; 68():66-75. PubMed ID: 29017969
[TBL] [Abstract][Full Text] [Related]
4. β
Graff RM; Kunz HE; Agha NH; Baker FL; Laughlin M; Bigley AB; Markofski MM; LaVoy EC; Katsanis E; Bond RA; Bollard CM; Simpson RJ
Brain Behav Immun; 2018 Nov; 74():143-153. PubMed ID: 30172948
[TBL] [Abstract][Full Text] [Related]
5. A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy.
Spielmann G; Bollard CM; Kunz H; Hanley PJ; Simpson RJ
Sci Rep; 2016 May; 6():25852. PubMed ID: 27181409
[TBL] [Abstract][Full Text] [Related]
6. High-intensity interval training in allogeneic adoptive T-cell immunotherapy - a big HIT?
Heinemann NC; Tischer-Zimmermann S; Wittke TC; Eigendorf J; Kerling A; Framke T; Melk A; Heuft HG; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
J Transl Med; 2020 Apr; 18(1):148. PubMed ID: 32238166
[TBL] [Abstract][Full Text] [Related]
7. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults.
Galletta TJ; Lane A; Lutzko C; Leemhuis T; Cancelas JA; Khoury R; Wang YM; Hanley PJ; Keller MD; Bollard CM; Davies SM; Grimley MS; Rubinstein JD
Transplant Cell Ther; 2023 May; 29(5):305-310. PubMed ID: 36736781
[TBL] [Abstract][Full Text] [Related]
8. A single exercise bout augments adenovirus-specific T-cell mobilization and function.
Kunz HE; Spielmann G; Agha NH; O'Connor DP; Bollard CM; Simpson RJ
Physiol Behav; 2018 Oct; 194():56-65. PubMed ID: 29723594
[TBL] [Abstract][Full Text] [Related]
9. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
Tzannou I; Papadopoulou A; Naik S; Leung K; Martinez CA; Ramos CA; Carrum G; Sasa G; Lulla P; Watanabe A; Kuvalekar M; Gee AP; Wu MF; Liu H; Grilley BJ; Krance RA; Gottschalk S; Brenner MK; Rooney CM; Heslop HE; Leen AM; Omer B
J Clin Oncol; 2017 Nov; 35(31):3547-3557. PubMed ID: 28783452
[TBL] [Abstract][Full Text] [Related]
10. The effects of normoxic endurance exercise on erythropoietin (EPO) production and the impact of selective β
Azadan RJ; Agha NH; Kunz HE; Baker FL; Mylabathula PL; Ledoux TA; O'Connor DP; Pedlar CR; Simpson RJ
Eur J Appl Physiol; 2021 May; 121(5):1499-1511. PubMed ID: 33646423
[TBL] [Abstract][Full Text] [Related]
11. Generation of multivirus-specific T cells by a single stimulation of peripheral blood mononuclear cells with a peptide mixture using serum-free medium.
Nishiyama-Fujita Y; Kawana-Tachikawa AI; Ono T; Tanaka Y; Kato T; Heslop HE; Morio T; Takahashi S
Cytotherapy; 2018 Sep; 20(9):1182-1190. PubMed ID: 30122653
[TBL] [Abstract][Full Text] [Related]
12. Transgenic CD8αβ co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells.
Bajwa G; Lanz I; Cardenas M; Brenner MK; Arber C
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33148692
[TBL] [Abstract][Full Text] [Related]
13. Identification of the best-suited donor for generating virus-specific T cells.
Tasnády S; Karászi É; Szederjesi A; Bihari G; Juhász Z; Hardi A; Kriván G; Kállay K; Reményi P; Sinkó J; Mikala G; Réti M; Masszi T
Vox Sang; 2020 Jan; 115(1):18-26. PubMed ID: 31667887
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study.
Campidelli A; Qian C; Laroye C; Decot V; Reppel L; D'aveni M; Bensoussan D
Cytotherapy; 2018 Apr; 20(4):524-531. PubMed ID: 29496461
[TBL] [Abstract][Full Text] [Related]
15. T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.
Keller MD; Darko S; Lang H; Ransier A; Lazarski CA; Wang Y; Hanley PJ; Davila BJ; Heimall JR; Ambinder RF; Barrett AJ; Rooney CM; Heslop HE; Douek DC; Bollard CM
Br J Haematol; 2019 Oct; 187(2):206-218. PubMed ID: 31219185
[TBL] [Abstract][Full Text] [Related]
16. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.
Papadopoulou A; Gerdemann U; Katari UL; Tzannou I; Liu H; Martinez C; Leung K; Carrum G; Gee AP; Vera JF; Krance RA; Brenner MK; Rooney CM; Heslop HE; Leen AM
Sci Transl Med; 2014 Jun; 6(242):242ra83. PubMed ID: 24964991
[TBL] [Abstract][Full Text] [Related]
17. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
[TBL] [Abstract][Full Text] [Related]
18. Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application.
Sun J; Huye LE; Lapteva N; Mamonkin M; Hiregange M; Ballard B; Dakhova O; Raghavan D; Durett AG; Perna SK; Omer B; Rollins LA; Leen AM; Vera JF; Dotti G; Gee AP; Brenner MK; Myers DG; Rooney CM
J Immunother Cancer; 2015; 3():5. PubMed ID: 25734008
[TBL] [Abstract][Full Text] [Related]
19. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.
Cruz CR; Micklethwaite KP; Savoldo B; Ramos CA; Lam S; Ku S; Diouf O; Liu E; Barrett AJ; Ito S; Shpall EJ; Krance RA; Kamble RT; Carrum G; Hosing CM; Gee AP; Mei Z; Grilley BJ; Heslop HE; Rooney CM; Brenner MK; Bollard CM; Dotti G
Blood; 2013 Oct; 122(17):2965-73. PubMed ID: 24030379
[TBL] [Abstract][Full Text] [Related]
20. Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.
Qian C; Campidelli A; Wang Y; Cai H; Venard V; Jeulin H; Dalle JH; Pochon C; D'aveni M; Bruno B; Paillard C; Vigouroux S; Jubert C; Ceballos P; Marie-Cardine A; Galambrun C; Cholle C; Clerc Urmes I; Petitpain N; De Carvalho Bittencourt M; Decot V; Reppel L; Salmon A; Clement L; Bensoussan D
J Hematol Oncol; 2017 May; 10(1):102. PubMed ID: 28482908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
